Conduit Pharmaceuticals Inc [NASDAQ: CDT] traded at a high on Monday, posting a 1.54 gain after which it closed the day’ session at $0.07.
The results of the trading session contributed to over 24977342 shares changing hands. Over the past one week, the price volatility of Conduit Pharmaceuticals Inc stands at 20.74% while the volatility over the past one month is 15.65%.
The market cap for CDT stock reached $8.15 million, with 96.00 million shares outstanding and 72.97 million shares in the current float. Compared to the average trading volume of 27.03M shares, CDT reached a trading volume of 24977342 in the most recent trading day, which is why market watchdogs consider the stock to be active.
How has CDT stock performed recently?
Conduit Pharmaceuticals Inc [CDT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 20.30. With this latest performance, CDT shares dropped by -25.00% in over the last four-week period, additionally sinking by -85.54% over the last 6 months – not to mention a drop of -98.52% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CDT stock in for the last two-week period is set at 46.10, with the RSI for the last a single of trading hit 48.73, and the three-weeks RSI is set at 44.02 for Conduit Pharmaceuticals Inc [CDT]. The present Moving Average for the last 50 days of trading for this stock 0.0896, while it was recorded at 0.0728 for the last single week of trading, and 1.0750 for the last 200 days.
Conduit Pharmaceuticals Inc [CDT]: Deeper insight into the fundamentals
Conduit Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.12 and a Current Ratio set at 0.12.
Insider trade positions for Conduit Pharmaceuticals Inc [CDT]
There are presently around $4.06%, or 7.97%% of CDT stock, in the hands of institutional investors.
